Form 4 for BNTC Benitec Biopharma Inc.
Accepted 2024-09-30 00:00:00 ET · period of report 2024-09-26 · accession 0000899140-24-001042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-09-30 | 2024-09-26 | BNTC | Averill Master Fund, Ltd. | Dir, 10% | X - OptEx | $2.96 | +7.14M | 6.66M | New | +$21.14M |
| DMI | 2024-09-30 | 2024-09-26 | BNTC | Averill Master Fund, Ltd. | Dir, 10% | X - OptEx | $0.00 | -16.55M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.0001 per share | 2024-09-26 | X | A | 1,219,970 | $0.00 | 7,883,385 | I See footnotes | — | — | (F4) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |
| 2 | Common | Common stock, par value $0.0001 per share | 2024-09-26 | X | A | 576,347 | $3.86 | 797,458 | I See footnotes | — | — | (F5) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |
| 3 | Common | Common stock, par value $0.0001 per share | 2024-09-26 | X | A | 148,210 | $0.00 | 945,668 | I See footnotes | — | — | (F6) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |
| 4 | Common | Common stock, par value $0.0001 per share | 2024-09-26 | X | A | 588,236 | $1.93 | 2,058,415 | I See footnotes | — | — | (F2) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |
| 5 | Common | Common stock, par value $0.0001 per share | 2024-09-26 | X | A | 4,605,000 | $3.86 | 6,663,415 | I See footnotes | — | — | (F3) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |
| 6 | Derivative | Pre-Funded Warrants | 2024-09-26 | X | D | 148,210 | $0.00 | 428,137 | I See footnotes | $0.00 · 2023-08-11 to — | 576,347 Common Stock | (F1) Notes are included on Exhibit 99.1. (F6) Notes are included on Exhibit 99.1. (F7) Notes are included on Exhibit 99.1. |
| 7 | Derivative | Pre-Funded Warrants | 2024-09-26 | X | D | 1,219,970 | $0.00 | 3,385,030 | I See footnotes | $0.00 · 2023-08-11 to — | 4,605,000 Common Stock | (F1) Notes are included on Exhibit 99.1. (F4) Notes are included on Exhibit 99.1. (F7) Notes are included on Exhibit 99.1. |
| 8 | Derivative | Common Warrants | 2024-09-26 | X | D | 4,605,000 | $0.00 | 0 | I See footnotes | $3.86 · 2023-08-11 to 2028-08-11 | 4,605,000 Common Stock | (F1) Notes are included on Exhibit 99.1. (F3) Notes are included on Exhibit 99.1. |
| 9 | Derivative | Series 2 Common Warrants | 2024-09-26 | X | D | 10,000,000 | $0.00 | 0 | I See footnotes | $1.93 · 2022-12-09 to 2027-12-09 | 588,236 Common Stock | (F1) Notes are included on Exhibit 99.1. (F2) Notes are included on Exhibit 99.1. |
| 10 | Derivative | Common Warrants | 2024-09-26 | X | D | 576,347 | $0.00 | 0 | I See footnotes | $3.86 · 2023-08-11 to 2028-08-11 | 576,347 Common Stock | (F1) Notes are included on Exhibit 99.1. (F5) Notes are included on Exhibit 99.1. |